The Emerging Role of LPA As an Oncometabolite

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2024 Apr 12

PMID 38607068

Authors

Theodoros Karalis

George Poulogiannis

Affiliations

Soon will be listed here.

Abstract

Lysophosphatidic acid (LPA) is a phospholipid that displays potent signalling activities that are regulated in both an autocrine and paracrine manner. It can be found both extra- and intracellularly, where it interacts with different receptors to activate signalling pathways that regulate a plethora of cellular processes, including mitosis, proliferation and migration. LPA metabolism is complex, and its biosynthesis and catabolism are under tight control to ensure proper LPA levels in the body. In cancer patient specimens, LPA levels are frequently higher compared to those of healthy individuals and often correlate with poor responses and more aggressive disease. Accordingly, LPA, through promoting cancer cell migration and invasion, enhances the metastasis and dissemination of tumour cells. In this review, we summarise the role of LPA in the regulation of critical aspects of tumour biology and further discuss the available pre-clinical and clinical evidence regarding the feasibility and efficacy of targeting LPA metabolism for effective anticancer therapy.

Citing Articles

From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.

Briand-Mesange F, Gennero I, Salles J, Trudel S, Dahan L, Ausseil J Molecules. 2024; 29(15).

PMID: 39125098 PMC: 11314389. DOI: 10.3390/molecules29153694.

References

Zheng Q, Dai X, Fang W, Zheng Y, Zhang J, Liu Y . Overexpression of microRNA-367 inhibits angiogenesis in ovarian cancer by downregulating the expression of LPA1. Cancer Cell Int. 2020; 20:476. PMC: 7531134. DOI: 10.1186/s12935-020-01551-x. View

Abdelmessih R, Xu J, Hung F, Auguste D . Integration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer. Mol Pharm. 2023; 20(11):5500-5514. PMC: 10631474. DOI: 10.1021/acs.molpharmaceut.3c00348. View

Takai M, Takauchi M, Kuribayashi M, Tsujiuchi T . LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions. Biochem Biophys Res Commun. 2023; 661:21-27. DOI: 10.1016/j.bbrc.2023.04.036. View

Matas-Rico E, Frijlink E, van der Haar Avila I, Menegakis A, van Zon M, Morris A . Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8 T cells. Cell Rep. 2021; 37(7):110013. PMC: 8761359. DOI: 10.1016/j.celrep.2021.110013. View

Kai M, Wada I, Imai S, Sakane F, Kanoh H . Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase. J Biol Chem. 1997; 272(39):24572-8. DOI: 10.1074/jbc.272.39.24572. View

Ojasalu K, Lieber S, Sokol A, Nist A, Stiewe T, Bullwinkel I . The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis. Theranostics. 2023; 13(6):1921-1948. PMC: 10091871. DOI: 10.7150/thno.81656. View

Song M, Suh P . O-GlcNAcylation regulates lysophosphatidic acid-induced cell migration by regulating ERM family proteins. FEBS Open Bio. 2022; 12(6):1220-1229. PMC: 9157403. DOI: 10.1002/2211-5463.13404. View

Sheng X, Yung Y, Chen A, Chun J . Lysophosphatidic acid signalling in development. Development. 2015; 142(8):1390-5. PMC: 4392601. DOI: 10.1242/dev.121723. View

Holmstrom T, Mattsson C, Wang Y, Iakovleva I, Petrovic N, Nedergaard J . Non-transactivational, dual pathways for LPA-induced Erk1/2 activation in primary cultures of brown pre-adipocytes. Exp Cell Res. 2010; 316(16):2664-75. DOI: 10.1016/j.yexcr.2010.05.029. View

10.

Tigyi G, Lin K, Jang I, Lee S . Revisiting the role of lysophosphatidic acid in stem cell biology. Exp Biol Med (Maywood). 2021; 246(16):1802-1809. PMC: 8381701. DOI: 10.1177/15353702211019283. View

11.

Liao Y, Liu L, Yang J, Shi Z . ATX/LPA axis regulates FAK activation, cell proliferation, apoptosis, and motility in human pancreatic cancer cells. In Vitro Cell Dev Biol Anim. 2022; 58(4):307-315. DOI: 10.1007/s11626-022-00660-3. View

12.

Tham C, Lin F, Rao T, Yu N, Webb M . Microglial activation state and lysophospholipid acid receptor expression. Int J Dev Neurosci. 2003; 21(8):431-43. DOI: 10.1016/j.ijdevneu.2003.09.003. View

13.

Zhao H, Jia P, Nanding K, Wu M, Bai X, Morigen M . Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression EGFR-PI3K/Aurora-A-geminin dual signaling pathways. Front Pharmacol. 2023; 13:1046269. PMC: 9806123. DOI: 10.3389/fphar.2022.1046269. View

14.

Zheng Y, Voice J, Kong Y, Goetzl E . Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. FASEB J. 2000; 14(15):2387-9. DOI: 10.1096/fj.00-0492fje. View

15.

Schmidt J, Yvone G, Brown W . Membrane topology of human AGPAT3 (LPAAT3). Biochem Biophys Res Commun. 2010; 397(4):661-7. PMC: 2902680. DOI: 10.1016/j.bbrc.2010.05.149. View

16.

Yuan X, Jin M, Xu X, Song Y, Wu C, Poo M . Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat Cell Biol. 2003; 5(1):38-45. DOI: 10.1038/ncb895. View

17.

Sun K, Chen R, Li J, Luo Z . LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Hereditas. 2022; 159(1):16. PMC: 8896370. DOI: 10.1186/s41065-022-00229-w. View

18.

Subauste A, Das A, Li X, Elliott B, Elliot B, Evans C . Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes. 2012; 61(11):2922-31. PMC: 3478532. DOI: 10.2337/db12-0004. View

19.

Fujimori Y, Kudo I, Fujita K, Inoue K . Characteristics of lysophospholipase activity expressed by cytosolic phospholipase A2. Eur J Biochem. 1993; 218(2):629-35. DOI: 10.1111/j.1432-1033.1993.tb18416.x. View

20.

Salgado-Polo F, Borza R, Matsoukas M, Marsais F, Jagerschmidt C, Waeckel L . Autotaxin facilitates selective LPA receptor signaling. Cell Chem Biol. 2023; 30(1):69-84.e14. DOI: 10.1016/j.chembiol.2022.12.006. View